https://to.holway.dev/study/treatment-of-crohns-disease-with-cannabis-an-observational-study/2019-08-26T18:40:44+00:00https://to.holway.dev/study/cannabis-induces-a-clinical-response-in-patients-with-crohns-disease-a-randomized-placebo-controlled-double-blind-study/2019-08-26T18:34:34+00:00https://to.holway.dev/study/2320/2019-03-31T21:02:58+00:00https://to.holway.dev/study/medical-cannabis-in-parkinsons-disease/2019-03-31T21:05:18+00:00https://to.holway.dev/study/epidemiological-characteristics-safety-and-efficacy-of-medical-cannabis-in-the-elderly/2019-03-31T21:31:55+00:00https://to.holway.dev/study/prospective-analysis-of-safety-and-efficacy-of-medical-cannabis-in-large-unselected-population-of-patients-with-cancer/2019-03-31T21:34:04+00:00https://to.holway.dev/study/medical-cannabis-for-pediatric-moderate-to-severe-complex-motor-disorders/2019-03-31T21:36:57+00:00https://to.holway.dev/study/avidekel-cannabis-extracts-and-cannabidiol-are-as-efficient-as-copaxone-in-suppressing-eae-in-sjs-j-mice/2019-08-26T18:42:00+00:00https://to.holway.dev/study/single-center-experience-with-medical-cannabis-in-gilles-de-la-tourette-syndrome/2019-03-31T21:39:19+00:00https://to.holway.dev/study/real-life-experience-of-medical-cannabis-with-autism-analysis-of-safety-and-efficacy/2019-08-26T18:30:33+00:00https://to.holway.dev/study/safety-and-efficacy-of-medical-cannabis-in-fibromyalgia/2019-06-17T23:35:08+00:00https://to.holway.dev/study/the-effects-of-cannabis-on-crohns-disease/2019-08-02T18:01:38+00:00https://to.holway.dev/study/the-effects-of-cannabis-on-colitis/2019-08-02T18:02:25+00:00https://to.holway.dev/study/cannabis-and-ibd-data-collection/2019-08-02T18:05:18+00:00https://to.holway.dev/study/the-effects-of-cannabis-on-immune-response/2019-08-02T18:42:19+00:00https://to.holway.dev/study/cannabidiol-rich-cannabis-in-children-with-autism-spectrum-disorder-and-severe-behavioral-problems/2019-08-26T23:31:14+00:00